Trial NCT03190213

View at ClinicalTrials.gov 
Org. Study IDs: HCI102310

Last trial update was posted on 2021-06-22

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma, Neuroendocrine Neuroendocrine Tumors

Other Conditions


Stopping Reasons

Update on clinical development: after discussions with the drug manufacturer, the PI has decided to discontinue the trial.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID